12789604

Source:http://linkedlifedata.com/resource/pubmed/id/12789604

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0253355
pubmed:issue	5
pubmed:dateCreated	2003-6-5
pubmed:abstractText	Novuspharma is developing pixantrone, a second-generation, well-tolerated anthracenedione analog, for the potential treatment of lymphoma and multiple sclerosis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883655
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Isoquinolines, http://linkedlifedata.com/resource/pubmed/chemical/Topoisomerase II Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/pixantrone
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1369-7056
pubmed:author	pubmed-author:BorchmannPeterP, pubmed-author:ReiserMarcelM
pubmed:issnType	Print
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	486-90
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:12789604-Animals, pubmed-meshheading:12789604-Hematologic Neoplasms, pubmed-meshheading:12789604-Humans, pubmed-meshheading:12789604-Isoquinolines, pubmed-meshheading:12789604-Technology, Pharmaceutical, pubmed-meshheading:12789604-Topoisomerase II Inhibitors
pubmed:year	2003
pubmed:articleTitle	Pixantrone (Novuspharma).
pubmed:affiliation	University of Cologne, First Department of Internal Medicine, Joseph-Stelzmann Strasse 9, 50924 Koeln, Germany. peter.borchmann@uni-koeln.de
pubmed:publicationType	Journal Article, Review